Artwork

Innehåll tillhandahållet av ICR. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av ICR eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Chris Hall, CEO and President, Personalis Inc. – A Prescription for Prosperity: Fueling medical breakthroughs with cutting-edge tech and strategic alliances

29:50
 
Dela
 

Manage episode 409062361 series 3281544
Innehåll tillhandahållet av ICR. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av ICR eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Big healthcare challenges demand cutting-edge healthcare products. Today's guest is building strategic partnerships to get ahead of disease and fuel the growth of their company.

Today we're sitting down with Chris Hall, CEO and President of Personalis, which trades under the symbol PSNL. In his role, Chris drives the vision and strategy for the company, including commercializing its diagnostic product offerings. He brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health.

Previously he served as President, COO, and Chief Commercial Officer of Veracyte Inc, where he led the company's commercial entry into endocrinology and pulmonology and scaled its operational groups. Chris also served as an SVP and Chief Business Officer at Berkeley HeartLab, part of Celera Corporation, where he helped new product launches, and restructured operations to improve profitability and streamline delivery of services.

Chris holds a BA in political science from DePauw University and an MBA from Harvard.

Highlights:

  • Chris describes Personalis and their work (3:45)
  • Personalis' MRD test and how it works (6:25)
  • Chris walks us through Personalis' tech evolution (8:23)
  • Personalis' current partnerships and collaborations (10:24)
  • More about the internal team at Personalis (14:31)
  • Chris discusses Personalis' recent Medicare coverage announcement (16:09)
  • The current macro environment's effect on business (18:09)
  • 2023 highlights at Personalis (19:54)
  • Near-future growth and development goals for Personalis (22:25)
  • Leadership and company culture at Personalis (24:22)
  • Product development and long-term objectives (26:19)

Links:

Chris Hall on LinkedIn

Personalis on LinkedIn

Personalis Website

ICR LinkedIn

ICR Twitter

ICR Website

Feedback:

If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, marion@lowerstreet.co.

  continue reading

142 episoder

Artwork
iconDela
 
Manage episode 409062361 series 3281544
Innehåll tillhandahållet av ICR. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av ICR eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Big healthcare challenges demand cutting-edge healthcare products. Today's guest is building strategic partnerships to get ahead of disease and fuel the growth of their company.

Today we're sitting down with Chris Hall, CEO and President of Personalis, which trades under the symbol PSNL. In his role, Chris drives the vision and strategy for the company, including commercializing its diagnostic product offerings. He brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health.

Previously he served as President, COO, and Chief Commercial Officer of Veracyte Inc, where he led the company's commercial entry into endocrinology and pulmonology and scaled its operational groups. Chris also served as an SVP and Chief Business Officer at Berkeley HeartLab, part of Celera Corporation, where he helped new product launches, and restructured operations to improve profitability and streamline delivery of services.

Chris holds a BA in political science from DePauw University and an MBA from Harvard.

Highlights:

  • Chris describes Personalis and their work (3:45)
  • Personalis' MRD test and how it works (6:25)
  • Chris walks us through Personalis' tech evolution (8:23)
  • Personalis' current partnerships and collaborations (10:24)
  • More about the internal team at Personalis (14:31)
  • Chris discusses Personalis' recent Medicare coverage announcement (16:09)
  • The current macro environment's effect on business (18:09)
  • 2023 highlights at Personalis (19:54)
  • Near-future growth and development goals for Personalis (22:25)
  • Leadership and company culture at Personalis (24:22)
  • Product development and long-term objectives (26:19)

Links:

Chris Hall on LinkedIn

Personalis on LinkedIn

Personalis Website

ICR LinkedIn

ICR Twitter

ICR Website

Feedback:

If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, marion@lowerstreet.co.

  continue reading

142 episoder

همه قسمت ها

×
 
Loading …

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

 

Snabbguide